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ABSTRACT
A complex network of inflammatory genes is closely linked to somatic
cell transformation and malignant disease. Immune cells and their
associated molecules are responsible for detecting and eliminating
cancer cells as they establish themselves as the precursors of a
tumour. By the time a patient has a detectable solid tumour, cancer
cells have escaped the initial immune response mechanisms. Here,
we describe the development of a double binary zebrafish model that
enables regulatory programming of the myeloid cells as they respond
to oncogene-activated melanocytes to be explored, focussing on the
initial phasewhen cells become the precursors of cancer. A hormone-
inducible binary system allows for temporal control of expression of
different Ras oncogenes (NRasQ61K, HRasG12V and KRasG12V) in
melanocytes, leading to proliferation and changes in morphology of
the melanocytes. This model was coupled to binary cell-specific
biotagging models allowing in vivo biotinylation and subsequent
isolation of macrophage or neutrophil nuclei for regulatory profiling
of their active transcriptomes. Nuclear transcriptional profiling of
neutrophils, performed as they respond to the earliest precursors
of melanoma in vivo, revealed an intricate landscape of regulatory
factors that may promote progression to melanoma, including
Serpinb1l4, Fgf1, Fgf6, Cathepsin H, Galectin 1 and Galectin 3.
The model presented here provides a powerful platform to study the
myeloid response to the earliest precursors of melanoma.
KEY WORDS: Biotagging, Macrophage, Melanocyte, Neutrophil,
Oncogene, Zebrafish
INTRODUCTION
Immune cells and their associated molecules are responsible for
detecting and eliminating cancer cells and their precursors at early
stages of cancer development (Williams et al., 2016; de Visser et al.,
2006). A complex network of inflammatory genes is closely linked
to somatic cell transformation and malignant disease. Importantly,
analysis of the initial response of immune cells to cancer might lead
to the discovery of targets for both prevention and treatment. As
with pathogens, cancer cells can evade the immune system and as
such tumour growth and ultimately the emergence of clinically
detectable cancer is largely dependent on the capacity of cancerous
cells to evade andmanipulate the immune response (Blair and Cook,
2008). Myeloid cells are equipped with sensors for damage and
inflammation as well as subsequent effector mechanisms for
resolving inflammation (Feng et al., 2010). However, transformed
cells are able to shape the nature of the myeloid cells and evoke an
immunosuppressive response, enabling progression of the disease
(Engblom et al., 2016). Further studies are needed to understand the
different inflammatory signalling pathways in tumour initiation and
progression, and how they may be modulated for immunotherapy.
Because we cannot predict when and where transformed cells may
arise in the human host, little is known about the sterile
inflammatory signalling pathways that closely follow somatic cell
transformation (Feng et al., 2012).
The zebrafish is an accepted model in cancer research, with many
aspects of carcinogenesis being conserved between teleosts and
humans (White et al., 2013; Stern and Zon, 2003). Unlike
mammalian models, the zebrafish is easily amenable to techniques
that allow the study of both cancer initiation and progression (Feng
et al., 2010). Zebrafish are particularly useful in studying melanoma
because their melanocytes are externally visible and large single cells
can be directly visualised live (Ceol et al., 2008).
Previous transgenic zebrafish melanoma models used oncogenic
BRAFV600E (Patton et al., 2005), NRasQ61K (Dovey et al., 2009) and
HRasG12V (Michailidou et al., 2009; Anelli et al., 2009) under the
melanocyte-specific microphthalmia-associated transcription factor a
(mitfa) promoter, coupled to an additional mutation in the tumour
suppressor gene p53. In the mitfa-driven HRasG12V transgenic line,
melanoma development is rare but secondary mutations in genes
involved in the PI3K signalling pathway contribute to its occurrence
(Patton et al., 2005; Dovey et al., 2009; Anelli et al., 2009). Santoriello
et al. subsequently developed a conditional transgenic zebrafish line
that uses the Gal4 system and the melanocyte-specific kita promoter to
drive HRasG12V expression (Vallone et al., 2007; Santoriello et al.,
2010). kita:HRasG12V induced early-onset melanoma without
additional mutations in tumour suppressor genes. However, some
reports suggest that high levels of Gal4 expression can be toxic and
may result in developmental defects (Emelyanov and Parinov, 2008).
Moreover, upstream activating sequences (UAS) have been shown to
be susceptible to DNAmethylation leading to transcriptional silencing
of the transgene, which is minimal in the first generation but
exacerbated upon propagation through later generations (Goll et al.,
2009; Akitake et al., 2011).
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current zebrafish models for benign naevus and cutaneous
melanoma rely on the targeted expression of a human oncogene
in melanocytes, limiting the ability to control melanoma initiation.
Additionally, constitutive expression of the oncogene renders
maintenance of stable transgenic lines difficult because these
models may develop severe tumours before the fish reach
reproductive age (Nguyen et al., 2012).
To overcome these limitations, we set out to develop an inducible
system of melanoma initiation. Here, we report the generation of a
new inducible zebrafish model, specifically designed to study the
onset of melanoma using the mifepristone-inducible LexPR system
developed by Emelyanov and Parinov (Emelyanov and Parinov,
2008). Additionally, we have developed an innovative transgenic
zebrafish model system for in vivo biotinylation and subsequent
isolation of neutrophil (previously described in Kenyon et al., 2017)
and macrophage nuclei based on the biotagging method (Trinh
et al., 2017). Using this approach, it is possible to perform genome-
wide analysis of the active nuclear transcriptomes of neutrophils and
macrophages. By combining the biotagging approach that enables
isolation and analysis of either neutrophil or macrophage nuclei
with the inducible model for melanoma initiation, we have created a
powerful double binary system for regulatory profiling of myeloid
cells that respond to the precursors of melanoma. In a proof-of-
concept analysis, we reveal a number of interesting factors
upregulated by neutrophils responding to the oncogene-activated
melanocytes that may promote melanoma progression.
RESULTS
Generation of a binary inducible melanoma model
To generate an inducible model for the initiation of melanoma
tumorigenesis, we adapted a hormone-inducible binary system for
targeted gene expression in zebrafish, previously used to drive liver
carcinogenesis (Emelyanov and Parinov, 2008; Nguyen et al., 2012).
In this system, the transcriptional activator expressed by the
transgenic driver is a ligand-dependent chimeric transcription
factor, termed the LexPR transactivator. The LexPR transactivator
is a fusion protein containing the DNA-binding domain (DBD) of the
bacterial LexA repressor, a truncated ligand-binding domain (LBD)
of the human progesterone receptor and the activation domain of NF-
κB/p65 protein. The effector transgenic fish line harbours the
operator-promoter sequence, consisting of the synthetic LexA
operator fused to a minimal 35S promoter sequence from the
Cauliflower mosaic virus, upstream of the reporter gene. In the
presence of the progesterone agonist, mifepristone, which binds
within the LexPR transactivator, LexPR activates the transcription of
the target reporter gene by binding to the LexA-binding sites within
the LexA operon (LexOP) positioned upstream (Fig. 1A).
In our system, we placed the LexPR transactivator, followed by
Cerulean reporter, under the control of the melanocyte-specific
promoters kita and mitfa using bacterial artificial chromosome
(BAC)-mediated transgenesis (Fig. S1). Two melanocyte-specific
driver lines [TgBAC(kita:LexPR-Cerulean)ox123 (hereafter referred to
as kita:LexPR-Cerulean) and TgBAC(mitfa:LexPR-Cerulean)ox124
(hereafter referred to as mitfa:LexPR-Cerulean)] were generated
(Fig. 1B,C).
To generate the effector lines, different Ras oncogenes (NRasQ61K,
HRasG12V and KRasG12V) fused to an mCherry fluorescent reporter
were cloned downstream of the LexOP. The effector cassettes were
placed within a non-autonomous maize dissociation (Ds) element,
which allows for effective activator (Ac)-mediated genomic
integration using the transposase Ac/Ds (AcDs) system (Emelyanov
et al., 2006) (Fig. S1). This system is highly efficient and results in
multiple independent integrations into the zebrafish genome,
thus allowing for high-level expression of the Ras effectors
activated by LexPR in the context of oncogenic transformation.
Three Ras-effector lines were generated: Tg(Crysβ:ECFP-LexOP:
mCherry-NRasQ61K)ox125 (hereafter referred to as LexOP:mCherry-
NRasQ61K), Tg(Crysβ:ECFP-LexOP:mCherry-HRasG12V)ox126 and
Tg(Crysβ:ECFP-LexOP:mCherry-KRasG12V)ox127. The Ras-effector
lines all contain the selection marker enhanced cyan fluorescent
protein (ECFP) under the control of the lens-specific zebrafish crysβ
promoter (crystallin betaβ), which results in blue fluorescence in the
lens. This can be used to screen for transgene integration, without
driving the oncogene (Fig. 1D).
When a driver line is crossed to an effector line, in the presence of
the synthetic progesterone ligand, mifepristone, mCherry–Ras-
oncogene is transcribed only in melanocytes. Two different
melanocyte-specific driver lines (kita and mitfa) and three different
mCherry–Ras-oncogene lines were generated in this study, paving
the way for multiple combinations of the system. We characterised
two of these lines, Tg(kita:LexPR-Cerulean;Crysβ:ECFP-LexOP:
mCherry-NRasQ61K)ox129 (Fig. 1E) and Tg(mitfa:LexPR-Cerulean;
Crysβ:ECFP-LexOP:mCherry-NRasQ61K)ox130 (Fig. 1F) (hereafter
referred to as kita:LexPR;LexOP:NRasQ61K and mitfa:LexPR;
LexOP:NRasQ61K, respectively) and showed that, when embryos
positive for both alleles were reared in the presence of mifepristone,
melanocyte-specific expression of the mCherry-NRas fusion protein
was detected. Transformedmelanocytes are seen in pairs or clumps of
oncogene-activated red cells (as shown by the white arrowheads
in Fig. 1G-G‴), indicative of their proliferative potential. In the
mitfa:mCherry-NRasQ61K genotype, low levels of melanin were
occasionally observed in melanocytes expressing mCherry (data not
shown).
To assess and characterise the effect of mitfa- and kita-targeted
oncogene activation, we compared the proliferative potential and
morphology of control and activated melanocytes. We performed
this analysis at two different time points: at 5 days post-fertilisation
(dpf ) (Fig. 2A-C), when the melanocytes are likely to be post-
mitotic as the embryonic pigmentation pattern is thought to be
largely complete at 48 h post-fertilisation (Kelsh et al., 2009, 1996)
and at 12 dpf (Fig. 2D-I), just before the adult pigmentation
patterning commences at 2 weeks post-fertilisation (Rawls et al.,
2001).
To ensure optimal visualisation of the mCherry-NRasQ61K-
expressing melanocytes at 5 dpf, embryos were partially bleached to
ensure that excessive pigment in melanoblasts did not mask the
mCherry signal and the signal amplified with an anti-Cherry
antibody (Fig. 2A-B‴). A total of 5-9 z-stacks were acquired for the
dorsal cranial region of each larvae and the melanocytes were
counted within each corresponding plane (Fig. 2A-B‴). A nuclear
stain (magenta) was used to aid in the visualisation of individual
melanocytes (Fig. 2B). Strikingly, we observed that oncogene-
activated melanocytes were present in clusters spanning multiple
cell layers, in contrast to controls, where melanocytes lay within a
single basal skin layer (Fig. 2A′-B″). We sought to quantify the
degree of melanocyte proliferation in kita:mCherry-NRasQ61K and
mitfa:mCherry-NRasQ61K embryos by precisely counting the total
number of melanocytes within the outlined area in the presence and
absence of mifepristone (+/− mif ). Both kita and mitfa transgenic
lines showed a statistically significant increase (P<0.01 and
P<0.0001, respectively) in the number of melanocytes in the
region of interest at 5 dpf (Fig. 2C). To ensure that the increase in
melanocytes was a result of oncogene activation rather than an
artefact of mifepristone application, we quantified the number of
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melanocytes in 5-dpf embryos reared as previously stated in the
presence or absence of mifepristone at 5 dpf and could detect no
difference (Fig. S2). To characterise the progression of the
oncogene-activated cells at 12 dpf, we similarly examined both
morphology and the proliferative state of the cranial melanocytes.
As previously described, kita:mCherry-NRasQ61K embryos were
reared in the presence or absence of mifepristone. Whereas, in
control embryos, the melanocytes appear to round up at 12 dpf,
mCherry-NRasQ61K-expressing melanocytes exhibited an
elongated fibroblast-like shape (Fig. 2D,D′, Fig. S3). Although
larval melanophores are mostly replaced during larval-to-adult
metamorphosis, some melanophores leave their initial position to
form the stripes of the adult. Interestingly, these cells are
characterised as small round black cells and are increasingly
melanised (Parichy, 2006). To quantify the melanocytes, nuclear
stain (green) was used to aid in the counting and visualisation of
individual melanocytes cells (Fig. 2E,E′). Strikingly, cranial
melanocytes were clearly present as multinucleated clusters
compared to controls (Fig. 2E,E′). Melanocytes of control embryos
were present in a single plane, in contrast to the oncogene-activated
melanocytes, which were present in several overlapping layers of
interlinked cells (Fig. 2F). Quantification of the melanocytes within
the outlined area in Fig. 2D in the presence and absence of
mifepristone at 12 dpf (+/−mif) (Fig. 2G-H‴) revealed a statistically
Fig. 1. LexPR mifepristone-inducible model for melanocyte oncogenic activation. (A) Diagram of LexPR/LexOP inducible system. The LexPR driver
cassette consists of LexPR transactivator and aCerulean reporter under the control of melanocyte-specific promoters, kita ormitfa. The effector cassette contains
the Lex operator sequence (LexOP) fused to the mCherry–Ras-oncogene. mCherry-Ras fusion is transcribed in trans only in the presence of mifepristone, when
the LexPR transactivator-mifepristone complex binds to the LexOP sequence upstream of the oncogene expression cassette. (B,C) mitfa:LexPR-Cerulean
[TgBAC(mitfa:LexPR-Cerulean)ox124] and kita:LexPR-Cerulean [TgBAC(kita:LexPR-Cerulean)ox123] transactivator driver lines were characterised by expression
of LexPR transactivator and its cognate fluorescent protein Cerulean specifically in melanocytes. (D) LexOP:mCherry-NRas effector line [Tg(Crysβ:ECFP-
LexOP:mCherry-NRasQ61K)ox125] shows ECFP expression in the eye, but no oncogene transcription. (E,F) The melanocyte-specific expression of mCherry-
NRas in transgenic larvae harbouring both a transactivation driver and an oncogene effector allele [Tg(kita/mitfa:LexPR-Cerulean;LexOP:mCherry-
NRasQ61K)ox129/ox130] is activated by addition of 1 μM mifepristone to the embryo rearing solution. (G-G‴). Confocal z-stack projection of the dorsal view of the
melanocytes in the hindbrain region of a Tg(mitfa:LexPR-Cerulean;LexOP:mCherry-NRasQ61K)ox130 transgenic larvae shows brightfield view (G). LexPR-
Cerulean fusion (blue) (G′) and mifepristone-dependent activation of LexOP:mCherry-NRasQ61K fusion (red) (G″) and the overlap (purple) (G‴). Larvae were
partially bleached to attenuate the pigment and the mCherry signal was amplified with an anti-Cherry antibody. White arrowheads show Cerulean and mCherry
signal localised to the melanocytes. Scale bar: 25 μm.
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significant increase (P<0.0001) in the number of melanocytes in the
region of interest (Fig. 2I). All experiments are representative of two
or three individual experiments.
Establishment of a binary system for regulatory profiling in
myeloid cells
Genome-wide analysis of the regulatory networks that govern the
inflammatory response in vivo is complicated by the fact that
relatively small numbers of responding cells are present within
complex tissues. The current zebrafish lines for studying
macrophage and neutrophil function make use of fluorescent
reporters under the control of the mpeg1 and mpx promoters,
respectively (Ellett et al., 2011; Renshaw et al., 2006). These lines
have largely been used for functional studies at the cellular level,
allowing for a detailed examination of host-pathogen interactions,
comparative analysis of macrophage and neutrophil behaviours
Fig. 2. Morphology and proliferative capacity of oncogene-activated melanocytes. (A-A″) Composite images show confocal z-stack projection of the dorsal
views of the head of 5-dpf larvae without (A) and with mifepristone-dependent mCherry-NRasQ61K activation (red) in Tg(kita:LexPR-Cerulean;LexOP:mCherry-
NRas)ox12 (A′) and Tg(mitfa:LexPR-Cerulean;LexOP:mCherry-NRas)ox130 (A″). The melanocyte-specific expression of mCherry-NRas in transgenic larvae
harbouring both a transactivation driver and oncogene effector alleles was activated by addition of 1 μM mifepristone to the embryo rearing solution starting at
24 hpf. (B-B″) Representative image of the procedure used to facilitate counting of melanocytes shows a confocal z-stack projection of melanocytes (red) with a
single plane of nuclear stain (magenta). (C) Quantification of the number of melanocytes in the region indicated by the red outline in A, comparing larvae from
experimental (+mif ) kita:LexPR;LexOP:NRasQ61K (n=8) and mitfa:LexPR;LexOP:NRasQ61K (n=8) to controls (−mif, n=7). Graph shows means±s.e.m. Statistical
significance was determined by two-tailed unpaired Student’s t-test with Welch’s correction. (D,D′) Dorsal views of the head of 12-dpf larvae without (D) and with
(D′) mifepristone-dependent mCherry-NRasQ61K activation in Tg(kita:LexPR-Cerulean;LexOP:mCherry-NRas)ox12. (E,E′) Proliferative activity of activated
melanocytes (red) (E′) shown with a nuclear stain (green) as compared to controls (E). (F) Confocal z-stack projection of melanocytes (red). (G,H) Representative
image of the method used to facilitate counting of melanocytes shows a confocal z-stack projection of melanocytes (red) with a single plane of nuclear stain
(green) in the absence (G) and presence (H) of mifepristone. (I) Quantification of the number of melanocytes in the region indicated by the red outline in D,
comparing larvae from kita:LexPR;LexOP:NRasQ61K (n=8) with and without oncogene activation (+/−mif ). Graph shows means±s.e.m. Statistical significance
was determined by two-tailed unpaired Student’s t-test with Welch’s correction. **P<0.01; ****P<0.0001. Scale bars: (B) 25 μm; (E) 31 μm; (E′) 27 μm; (F) 28 μm;
(G) 25 μm and (H) 25 μm.
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responding to inflammation, and the dynamic interaction between
the two cell types (Renshaw et al., 2006; Ellett et al., 2011). Based
on the biotagging method (Trinh et al., 2017), we have developed a
zebrafish model to study the gene regulatory landscape of
macrophages and neutrophils by cell-specific in vivo biotagging
of nuclei, thereby enabling us to obtain the active transcriptome of
these cell types (Fig. 3A). In our system, the biotagging driver line
harbours cell-specifically (macrophage or neutrophil) expressed
E. coli biotin ligase BirA. Myeloid BirA driver lines
TgBAC(mpeg1:BirA-Citrine)ox122 [hereafter referred to as mpeg1:
BirA-Citrine (Fig. 3B) and TgBAC(mpx:BirA-Citrine)ox121
(hereafter referred to as mpx:BirA-Citrine (Fig. 3C) (described in
Kenyon et al., 2017)] were generated using BAC-mediated
transgenesis (Fig. S1). The previously characterised effector line
Tg(bactin:Avi-Cerulean-RanGap)ct700a (hereafter referred to as
bactin:Avi-Cerulean-Rangap) (Trinh et al., 2017) features
ubiquitous expression of a zebrafish-compatible version of Avi-
tagged nuclear-envelope-associated fusion protein. The Avi-tag is a
14-amino-acid minimal biotinylation substrate, specifically
biotinylated by biotin holoenzyme synthetase, BirA, which adds a
single biotin moiety onto a lysine residue within this peptide (de
Boer et al., 2003). In addition to the biotinylatable Avi-tag, this
effector protein consists of the carboxyl-terminal domain of Ran
GTPase-activating protein1 (RanGap1), which acts as an outer-
nuclear-envelope-targeting sequence, and a fluorescent variant
Cerulean, allowing visualisation of the fusion protein (Fig. 3D,E).
When the driver line is crossed to the effector line, in the specific
cells (neutrophils or macrophages) that carry both biotagging alleles
(driver and effector), the Avi-tagged fusion protein gets biotinylated
and localises to the outer nuclear envelope. This process effectively
results in the biotinylation of nuclei in a cell-specific (macrophage
or neutrophil) fashion, allowing isolation of nuclei from these cell
types using streptavidin-coated magnetic beads. Subsequently, the
content of these nuclei can be analysed in a genome-wide fashion by
next-generation sequencing (NGS) techniques. The use of mpeg1:
BirA-Citrine and mpx:BirA-Citrine drivers combined with the
Avi-Cerulean-Rangap effector offers the unique possibility to
interrogate initial, often crucial, regulatory responses in specific
cell types. Cell isolation protocols that are based on expression of
fluorescent reporters always feature a delay between the time of
expression of the cell-type-specific marker and the downstream
analysis, because the fluorophore requires a certain amount of time
to reach steady-state levels for visualisation or isolation by
fluorescence-activated cell sorting (FACS). Given that cell-
specific biotinylation begins very shortly after the cells start
expressing BirA, the use of the biotagging system minimises such
delays and enables faithful representation and readout of the
relevant cell states. This is particularly crucial for analysis of cell
populations in rapidly developing zebrafish embryos.
To show that the mpeg1/mpx driver lines generated in this study
faithfully recapitulate larval inflammatory phenotypes, tailfin
transections (Renshaw et al., 2006) were carried out at 3 dpf in
mpeg1:BirA-Citrine and mpx:BirA-Citrine embryos, respectively.
Injured specimens were fixed at 5 h post-injury (hpi) (mpeg1:BirA-
Fig. 3. Binary transgenic zebrafish model for regulatory profiling of myeloid cells. (A) Schematic of myeloid nuclear biotagging system. When biotagging
effector transgenic zebrafish line ubiquitously expressing Avi-tagged Rangap for biotinylation of nuclei is crossed to biotagging driver line expressing BirA in
myeloid-specific manner, only the macrophage or neutrophil nuclei will be biotinylated. (B) Transgene expression in macrophage-specific BirA driver,
TgBAC(mpeg1:BirA-Citrine)ox122, is amplified with anti-GFP–Alexa-Fluor-488 to show expression in macrophages. (C) TgBAC(mpx:BirA-Citrine)ox121 biotagging
transgenic driver shows neutrophil-specific expression. (D,E) Projection of confocal microscope images of Tg(bactin:Avi-Cerulean-Rangap)ct700a shows ubiquitous
expression of the biotag effector specifically on nuclei, across somite region of the embryo, with (D) and without (E) bright field background. The images in D and E
are taken in different embryos. (F,G) Tailfins of transgenic fish transected at 3 dpf show responding macrophages in mpeg1:BirA-Citrine (F) and neutrophils in
mpx:BirA-Citrine (G) larvae at 5 hpi or 1 hpi, respectively, as indicated by green arrows.
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Citrine) and 1 hpi (mpx:BirA-Citrine), and stained using anti-GFP
antibody to amplify the Citrine signal and thus detect macrophages
and neutrophils expressing BirA driver transgenes and their
associated fluorescent reporter. Both mpeg1:BirA-Citrine
(Fig. 3F) and mpx:BirA-Citrine (Fig. 3G) showed infiltration of
macrophages and neutrophils to the site of injury.
Generation of a double binary system to study the myeloid
response to transformed melanocytes
To study the initial myeloid response to oncogene-transformed
melanocytes, we have generated a double binary system in zebrafish
by coupling the inducible LexPR driver/effector to the biotagging
system for nuclear transcriptional profiling of macrophages and
neutrophils (Fig. 4A, Fig. S4). Since NRasQ61K is the most relevant
oncogene to human melanoma, with 30% of melanomas having
contributing mutations in NRas (Ceol et al., 2008), it was prioritised
for the purpose of this study. We hypothesised that, if NRasQ61K-
transformed melanocytes generated by the inducible LexPR binary
system were immunogenic, an increase in neutrophils in proximity
to melanocytes following oncogene activation may be expected.
kita:LexPR;LexOP:NRasQ61K fish were in-crossed and embryos
were grown to 24 hpf, at which point mifepristone is added to the
embryo rearing medium in experimental embryos or omitted in non-
treatment controls. Larvae were reared until 5 dpf, fixed and stained
with an anti-mpx antibody to detect neutrophils. We chose to focus
on the cranial region as this would be the focus of future
experiments and capture only the neutrophils in the skin of the
larvae in the vicinity of the melanocytes as compared to the controls.
Images were captured as 11 z-stack projections to a depth of 100 μm
from the surface of the embryo in kita:LexPR;LexOP:NRasQ61K
(+mif) and in genotype and stage-matched controls (−mif) larvae,
and neutrophils were counted within the outlined area (Fig. 4B,B′).
We observed a significant increase in the number of neutrophils
when compared to stage- and genotype-matched controls with no
oncogene activation (P<0.01) (Fig. 4C). Furthermore, high-
resolution images show that neutrophils were detected in the
vicinity as well as directly interacting with the melanocytes in the
tail (Fig. 4D) and cranial region (Fig. 4D′) following oncogene
activation.
Transcriptional analysis of neutrophils in response to
NRasQ61K-transformed melanocytes by in vivo biotagging
To test the efficacy of this model, we carried out a proof-of-concept
study and performed transcriptional profiling of neutrophils
responding to NRasQ61K-activated melanocytes, with the aim to
identify components of the cellular response that might contribute to
tumour progression. All subsequent experiments were carried out by
crossing the kita:LexPR;LexOP:NRasQ61K inducible melanoma
Fig. 4.mCherry-NRasK61Q-activatedmelanocytes are
immunogenic. (A) Larvae at 5 dpi harbouring all four
alleles (blue eye, blue nuclei, green neutrophils and red
melanocytes) as captured on a Zeiss Z1 Light Sheet
microscope. kita:LexPR;LexOP:NRasQ61K were crossed
to mpx:BirA;bactin:Avi-Rangap, and mCherry-NRas
activated by addition of mifepristone. (B) The
melanocyte-specific oncogene NRasK61Q was activated
by addition of mifepristone to the E3 medium in Tg(kita:
LexPR-Cerulean;pCrysβ:ECFP-LexOP:mCherry-
NRasQ61K)ox129 embryos at 24 hpf. At 5 dpi, composite
confocal images show neutrophils (green) as detected
with an anti-mpx antibody in stage-matched controls
(−mif ) (B) and embryos where the oncogene had been
activated (+mif ) (B′). Images are a maximum intensity
projection of 11 z-stack projections captured from the
surface of the embryo to a depth of 100 μm.
(C) Quantification of the number of neutrophils in the
region of cranial melanocytes in the outlined area in B in
control larvae (−mif, n=8) and following oncogene
activation (+mif, n=8). Graph shows means±s.e.m.
Statistical significance was determined by two-tailed
unpaired Student’s t-test with Welch’s correction.
**P<0.01. (D) High-resolution image of neutrophils in the
tail (D) and head (D′) of 5-dpf zebrafish larvae following
oncogene activation at 24 hpf, as shown by the
arrowheads.
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system to the mpx:BirA;bactin:Avi-Rangap biotagging system,
allowing isolation of neutrophil nuclei responding to oncogene
activation. NRasQ61K expression in the melanocytes of resulting
embryos from this cross was driven by addition of mifepristone to the
water at 24 hpf. Embryos expressing mCherry-NRasQ61K in the
melanocytes were selected for the profiling experiments, allowed to
develop until 5 dpf and used for downstream analysis. Approximately
45 larvae from each condition – experimental (+mif) and control
(−mif) – were used per experiment. A total of three biological
replicates were collected. In each experiment, prior to nuclei isolation
and analysis, cranial regions containing major foci of melanocyte
oncogenic transformation were dissected to eliminate the anterior
yolk sac and intermediate cell mass (ICM), thus enriching for
responding neutrophils (Fig. 5A) (Bennett et al., 2001). By focussing
our analysis on the isolated oncogene-activated mCherry-expressing
regions in the head, we enriched the samples with environing
neutrophils responding to transformed melanocytes. Moreover,
mCherry-NRasQ61K-expressing goblet cells found in the trunk
region were excluded from the analysis.
‘Biotagged’ nuclei were isolated from dissected tissue by nuclei
pulldown. Nuclear RNA pools were extracted and libraries prepared
using SMART-seq™ v4 technology for cDNA synthesis and
amplification for small cell numbers followed by Illumina Nextera
library preparation. Libraries were sequenced on an NGS platform.
Scatterplots of technical replicates show reproducibility between
the three independent experiments (Fig. S5). Differential expression
analysis comparing active transcription in neutrophil nuclei of
embryos with NRas-transformed melanocytes versus control
embryos identified 194 upregulated genes and 144 downregulated
genes with a statistical significance cut off of P<0.05 (Fig. 5B,C,
Fig. S3, Table S1).
The analysis of RNA sequencing (RNA-seq) datasets showed that
a number of genes that may contribute to melanoma progression were
upregulated in neutrophils upon engaging with transformed
melanocytes. Those include mediators of tumour growth,
angiogenesis and extracellular matrix (ECM) remodelling (Fig. 5D,
Fig. S6), suggesting their potential pro-tumorigenic role in promoting
progression to melanoma. In addition, we found significant
enrichment for a number of factors involved in neutrophil
migration, adhesion and cytoskeletal rearrangement as well as key
factors involved in neutrophil biological processes (Fig. S6). To
confirm the results of the RNA-seq analysis, we performed
quantitative real-time PCR (qPCR) for a number of genes that were
upregulated in the RNA-seq analysis. We detected an increase in
serpinb1l4 transcripts (Fig. 5D). SerpinB1 is an inhibitor of
neutrophil serine proteases, including neutrophil granule proteins,
elastase and cathepsin G (Benarafa et al., 2011). One potential
mechanism by which neutrophils could eliminate transformed cells
is by proteases stored in neutrophil granules. This data suggests
that, instead, this mechanism is inhibited and neutrophils exhibit
an immunosuppressive phenotype, allowing for melanocyte
proliferation. We also detected an increase in members of the
fibroblast growth factor (FGF) family, fgf1 and fgf6 (Fig. 5E,F),
known to control cellular proliferation, survival, migration and
differentiation. Uncontrolled FGF signalling, implicated in diverse
tumour types, can drive tumorigenesis (Turner and Grose, 2010).
Notably, we detect a statistically significant increase in cathepsin H
(Fig. 5G). Cathepsins are a group of lysosomal proteinases or
endopeptidases, of which different members can play a role in
different tumorigenic processes, including proliferation, angiogenesis
and metastasis (Tan et al., 2013). Furthermore, we see a statistically
significant upregulation in members of the galectin family – galectin 3
and galectin 1 (Fig. 5H,I) – a group of proteins that bind
β-galactoside and whose expression correlates with tumour
development and invasiveness (Danguy et al., 2002). Other
upregulated transcripts as confirmed by qPCR include tgm,
dusp23 and calpain b (Fig. 5J-L).
The prolonged exposure (21 days) to the progesterone agonist
mifepristone has biological consequences at the level of gene
expression in zebrafish larvae and adults (Bluthgen et al., 2013). To
confirm that the transcriptional changes exhibited by the neutrophils
were a direct result of oncogene-activated melanocytes rather than the
4-day exposure to mifepristone, nuclei pulldowns were carried out in
mpx:BirA;bactin:Avi-Rangap fish. Embryos were grown to 24 hpf
and mifepristone added to the E3 medium of the experimental batch,
whereas control embryos were reared without mifepristone. Larvae
were reared until 5 dpf, nuclear pulldowns performed and
corresponding nuclear RNA pools extracted. Reverse transcription
(RT)-qPCR assaying a number of candidate genes found to be
upregulated in neutrophils upon the response to NRas activation in
melanocytes was carried out. We found little or no change in
transcript levels of tgm1, fgf6a, fgf1, cathepsin L, gstp2, calpain b,
galectin 1, galectin 3, dusp23, cathepsin H and serpinb14 upon the
addition of mifepristone (Fig. S7A-K), suggesting that the results
obtained after 4 days of exposure to mifepristone were a result of
activation of NRasQ61K rather than mifepristone exposure.
DISCUSSION
Although progress has been made in understanding melanoma
biology, the incidence of melanoma continues to increase and the
prognosis for melanoma patients still remains poor (Anelli et al.,
2009). Here, we report an inducible model to study the molecular
mechanisms following oncogene activation in melanocytes that
allows for the spatiotemporal control of oncogene expression in
zebrafish melanocytes and thus the potential to study the earliest
precursors of melanoma. Additionally, we have developed a binary
model designed for regulatory nuclear profiling of myeloid cells.
Coupled together, these systems provide the potential to understand
the mechanisms by which macrophages and neutrophils may
promote melanoma progression or conversely eliminate cancer cells
as they establish themselves as the precursors of a tumour. Although
not described in this study, the biotagging model can be extended to
purification of ribosomes using the translating ribosomal affinity
purification method (TRAP) based on the in vivo biotinylation of the
Avi-tagged Rpl10 protein in zebrafish (Heiman et al., 2008; Trinh
et al., 2017). A full understanding of the RNA landscape of
neutrophils at the onset of melanoma would require both ribosomal
and nuclear profiling to obtain the translated and active
transcriptome, respectively (Trinh et al., 2017).
Importantly, in combination or as individual systems, both binary
models presented in this study provide the potential to study
different aspects of melanoma biology, including the transformation
of melanocytes, myeloid immunity and immunotherapy. For
example, the larval phenotype observed in this zebrafish
melanoma model can provide a powerful platform for testing drug
targets for preclinical testing of therapeutics. Because of the larval
phenotype that we see, the mCherry-positive transformed cells can
provide a direct biological readout in fast, easy-to-score chemical
screens, aimed at finding compounds or drugs that may revert the
overproliferation phenotype observed in melanocytes. Previous
studies have shown that activated components of the Ras signalling
pathway drive a tumour-promoting inflammatory response (Feng
et al., 2010). However, these findings do not address the difference
in the inflammatory response that different driver mutations may
7
RESOURCE ARTICLE Disease Models & Mechanisms (2018) 11, dmm030056. doi:10.1242/dmm.030056
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
Fig. 5. Analysisof technical replicates toobtain differentiallyexpressedgenes. (A) Schematic of dissection of 5-dpf larvae for nuclear profiling of neutrophils in the
presence or absence of NRasQ61K-transformed cranial melanocytes. Cranial regions are dissected away from the trunk to eliminate neutrophils from the
anterior yolk sac and ICM, enriching for responding neutrophils. (B) Volcano plot of differential expression analysis of activated NRasQ61K and control embryos shows
the relationship between P-value and log fold change (red, upregulated; blue, downregulated) shows 194 upregulated genes (red) and 144 downregulated genes
(blue) in cranial neutrophils. (C) Heat map shows the log10 [normalised counts (NMCT) +0.01] of selected differentially expressed transcripts (adjusted P-value <0.05).
Red, high expression; yellow, medium expression; blue, low expression. Selected differentially expressed transcripts were further classified into subcategories of
‘angiogenesis and ECM remodelling’ (purple), ‘cytoskeletal rearrangement, adhesion and migration’ (green), ‘growth factors and receptors’ (pink) and ‘immune/
neutrophil biological processes’ (turquoise). (D-L) Bar graphs represent mRNA levels of upregulated transcripts in controls vs NRasQ61K-activated embryos as
measured by qPCR in 2-3 replicate experiments. serpinb1l4 (D), fgf1 (E), fgf6 (F), cathepsin H (G), galectin 3 (H), galectin 1 (I), tgm (J), dusp23 (K) and calpain b (L).
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elicit. In our model, the same driver line can be crossed to multiple
oncogene effector lines. This provides further opportunities to study
mechanistic details of melanoma initiation and progression with
different driver mutations.
In this proof-of-concept study, we chose to use this model system
to profile the neutrophil response to NRasQ61K-oncogene-activated
melanocytes using the kita driver. Neoplastic cells may only initiate
tumour formation in the context of a supportive tumour
microenvironment, largely influenced by myeloid cells. Although
an immunosuppressive mechanism for neutrophils has been
demonstrated in solid tumours, the role for neutrophils in tumour
initiation largely remains to be explored. Although it is now
accepted that tumour-associated neutrophils develop a pro-
tumorigenic phenotype, largely driven by the presence of TGF-β,
inhibition of TGF-β can modulate the cells to be tumouridical
(Fridlender et al., 2009). In untreated tumours, neutrophils were
reported to contribute to tumorigenesis by secreting factors that
promote tumour growth, ECM remodelling and suppress the
immune system (Galdiero et al., 2013). A study using a Tet-on
inducible transgenic zebrafish line expressing oncogenic KRasG12V
in hepatocytes resulted in accelerated hepatocellular carcinoma
(HCC) (Chew et al., 2014; Yan et al., 2017). The authors attributed
the gender disparity of HCC, which occurs more frequently and
aggressively in men than in women, to differences in cortisol levels,
and reported a higher number of tumour-infiltrating neutrophils and
macrophages in male zebrafish. After 7 days of doxycycline
exposure in 3-month-old zebrafish, both infiltrating macrophages
and neutrophils had a pro-tumour gene expression profile, although
the effect was higher in male zebrafish than in their female
counterparts (Yan et al., 2017).
We show here that neutrophils responding to early melanoma
onset may provide an early source of Fgf1 and Fgf6. Given the
multiple functional roles for FGF signalling in different tumours,
the strong enrichment in FGF components in the neutrophils
responding to oncogene-transformed melanocytes suggests a pro-
tumorigenic role in promoting progression to melanoma. For
example, uncontrolled FGF signalling in tumours can lead to both
expansive tumour growth and progression to metastasis (Korc and
Friesel, 2009). Furthermore, as FGF signalling can also promote
angiogenesis, it is possible that the early role of FGFs in
melanoma may be linked to angiogenesis, which not only
promotes tumour growth but also the advancement from a pre-
malignant to a malignant phenotype (Massi et al., 2010; Yang
et al., 2015). In line with this interpretation, excessive
angiogenesis, a hallmark of melanoma, and the progression from
a radial growth phase to a vertical growth phase has been shown to
require high angiogenic activity dependent on FGF1, FGF2 and
VEGFA (Massi et al., 2010). In particular, FGF1 is a direct
activator of phosphatidyl inositol 3-kinase (PI3K)-AKT signalling
in endothelial cells known to initiate migration and invasion (Yang
et al., 2015). These findings are particularly meaningful given that
naturally targeting paracrine signalling in the form of growth and
angiogenic factors is poised to provide exciting targets for cancer
therapy.
Traditionally, cysteine cathepsin proteases are largely accepted as
degradative enzymes of the lysosome. More recently, secreted
cathepsins have emerged as potent effectors of multiple processes
during tumour development, including the turnover and degradation
of the ECM as well as processing or degradation of various growth
factors, cytokines and chemokines. Consequently, cathepsins may
promote tumour growth, tissue invasion and metastasis (Olson and
Joyce, 2015). In a model of pancreatic islet carcinogenesis, deletion
of cathepsin H significantly altered angiogenic switching of pre-
malignant hyperplastic islets and ultimately a reduction in the
number of tumours formed (Gocheva et al., 2010). Cathepsin H
activity was largely attributed to macrophages in close proximity to
the blood vessels (Gocheva et al., 2010). Here, we provide evidence
that neutrophils may provide a source of cathepsin H in melanoma
initiation.
Another interesting class of molecules implicated in tumour
progression are the galectins, a family of lectin carbohydrate-binding
proteins that function both intracellularly and extracellularly
(Fortuna-Costa et al., 2014). Multiple examples exist in the
literature for the role of galectins in tumour progression, including
facilitating neoplastic transformation, tumour cell survival,
angiogenesis and tumour metastasis (Liu and Rabinovich, 2005).
Galectin 1, for example, increases cellular growth and exerts its
effects by binding to the ECM as well as other cells (Liu and
Rabinovich, 2005). In melanoma, galectin 1 has been thought to
cause resistance of melanoma cells to cytotoxic stimuli and to
enhance angiogenesis (Mathieu et al., 2012). Extracellular galectin 3
may influence tumour progression by impeding the endocytosis of
key receptors, including TGFβ and EGF, while at the same time
inducing endocytosis of β1 integrins (Furtak et al., 2001; Partridge
et al., 2004). Extracellular galectin 3 secreted by tumour cells has also
been shown to induce angiogenesis (Liu and Rabinovich, 2005).
Furthermore, since galectins are expressed by immune cells, both
intracellular and extracellular galectins may serve to regulate immune
cell function (Liu and Rabinovich, 2005). Galectin 1 inhibits the
release of inflammatory mediators by neutrophils and reduces
transendothelial migration of the cells in response to inflammatory
stimuli (Liu and Rabinovich, 2005; La et al., 2003). Therefore,
targeting galectins derived from neutrophils in benign neoplasms
may serve to prevent malignant transformation by promoting a pro-
inflammatory environment. Galectin 3, on the other hand, can
function as a chemokine attracting both monocytes and macrophages
(Sano et al., 2000). In this capacity, galectin 3 may facilitate tumour
progression driven by macrophages.
The zebrafish embryo has previously been used as a model
organism to study the interactions between macrophages and
neutrophils and oncogene-transformed melanocytes and goblet
cells using a kita:HRasG12V transgenic line (Feng et al., 2010).
This study revealed a recruitment of both neutrophils and
macrophages to oncogene-transformed cells. The authors reported
frequent cytoplasmic tethers between the immune cells and
transformed cells, including neutrophils, as well as phagocytosis of
transformed cells by macrophages (Feng et al., 2010). In agreement
with this data, we show, at the transcriptional level, an upregulation in
signallingmolecules involved in cell migration as well as cytoskeletal
reorganisation in neutrophils.
In conclusion, we developed a double binary transgenic system
for studying the myeloid response to the earliest precursors of
melanoma and demonstrated it as a powerful resource,
offering exciting potential to reveal inflammatory mediators that
may contribute to tumour promotion and progression. This
unbiased, genome-wide approach, carried out at the earliest
stages of somatic cell transformation in vivo, is currently the only
study of its kind. The ensuing gene set provides a list of interesting
pathways and specific candidates to explore further in human
melanoma biology. The results described here contribute to the
growing body of evidence that suggests a tumour-promoting role
of neutrophils in cancer biology and provides insight into the
mechanisms by which neutrophils can be harnessed for
immunotherapy.
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MATERIALS AND METHODS
Zebrafish maintenance and strains
This study was carried out in compliance with local ethical approval from
the University of Oxford (UK) and using procedures authorised by the UK
Home Office in accordance with UK law (Animals Scientific Procedures
Act 1986). Zebrafish were maintained as described previously (Westerfield,
2000). Wild-type embryos for transgenesis were obtained from AB or
AB/TL mix strains.
Transgenic fish line generation and maintenance
The pDs(cry:ECFP-LexOP:Cherry) construct was a kind gift from Dr
Alexander Emelyanov and Dr Sergey Parinov (Emelyanov and Parinov,
2008). pCrysβ:ECFP-LexOP:mCherry-NRasQ61K, pCrysβ:ECFP-LexOP:
mCherry-HRasG12V and Crysβ:ECFP-LexOP:Cherry-KRasG12V were
cloned by In-Fusion cloning (Clontech, cat. no. 638909) using pBabe-NRas
61K (plasmid #12543; Addgene), mEGFP-HRasG12V (plasmid #18666;
Addgene) and pEFm.6 HA-KRasv12 (a gift from Prof. Xin Lu, Ludwig
Institute for Cancer Research Oxford, Oxford, UK) were used as donor
vectors. The optimised open reading frame (ORF) of the LexPR transactivator,
which eliminates all putative donor and acceptor sites that could interfere with
proper production of the LexPR transcript, was synthesised based on the
coding sequence obtained from Dr Parinov (Temasek Life Sciences
Laboratory, National Institute of Singapore, Singapore) and assembled using
G-Blocks (Integrated DNATechnologies, BVBA, Leuven, Belgium). pGEM
LexPR-2A-Cerulean-SV40pA-FRT-Kan-FRT donor plasmid for BAC
transgenesis was cloned by In-Fusion cloning. pGEM BirA-2A-Citrine-
SV40pA-FRT-Kan-FRT donor plasmid for BAC transgenesis was cloned by
fusion PCRofHA-BirA-2A amplified fromPMT-HA-BirA-2A-mCherryRas
(Trinh et al., 2017) and inserted into pGEM-GFP-SV40pA-FRT-Kan-FRT
where the GFP ORF was been replaced with Citrine. All plasmids generated
for the purposes of this studyare listed inTableS2and available fromAddgene
(https://www.addgene.org/Tatjana_Sauka-Spengler/).
The TgBAC(mpeg1:BirA-Citrine)ox122 and TgBAC(kita/mitfa:LexPR-
Cerulean)ox123/ox124 transgenic lines were generated by BAC-mediated
transgenesis as previously described (Trinh et al., 2017). Briefly, PCR-
amplified BirA-2A-Citrine-SV40pA-FRT-Kan-FRT and LexPR-2A-
Cerulean-SV40pA-FRT-Kan-FRT cassettes were recombined into the first
coding exon of a driver gene within the corresponding BAC clone
(macrophage-specific mpeg1 gene, and melanocyte-specific mitfa or kita,
respectively). In a second recombination step, an iTol2-Ampicillin cassette
(provided by Prof. Kawakami, National Institute of Genetics, Mishima,
Japan) was introduced into the BAC backbone as previously published
(Suster et al., 2011; Bussmann and Schulte-Merker, 2011). Wild-type
embryos were injected at the one-cell stage with 200 ng/μl of purified BAC
DNA and 100 ng/μl tol2 transposase mRNA. Putative founders were
outcrossed to wild-type fish and offspring screened for Citrine or Cerulean
expression, in combination with PCR amplification of the transgene when
expression levels were low. The full list of zebrafish transgenic lines
generated and used in this study can be found in Table S3.
In transgenic embryos harbouring both a transactivation driver and
oncogene effector allele, melanocyte-specific expression of mCherry–Ras-
oncogene was activated by addition of 1 μM mifepristone (Sigma, cat. no.
M8046) to the E3 medium and changed daily.
Whole-mount immunofluorescence and imaging
Embryos/larvae were fixed in 4% PFA in phosphate buffered saline (PBS)
(0.1 M, pH 7.4) for 1 h at room temperature (RT). Embryos were bleached
(3% H2O2, 0.8% KOH and 0.5% Tween20) and post-fixed in 4% PFA in
PBS for 1 h at RT. Embryos were then rinsed 3×15 min in PBT (2%DMSO,
0.5% Triton in PBS) and incubated in block solution (10% donkey serum in
PBT) for 2 h at RT, followed by incubation with primary antibody (1:300 in
block solution) overnight (O/N) at 4°C. Embryos/larvae were then washed
3-5 times for 1 h at RT, followed by an O/N wash at 4°C in PBT and then
incubated with secondary antibody (1:1000 in PBT). Embryos were then
washed 6-8 times for 1 h at RT+O/N at 4°C in PBT. The primary antibody
used to detect neutrophils was rabbit anti-mpx (GeneTex, cat. no.
GTX128379) and the secondary antibody used was Alexa-Fluor-488-
conjugated anti-rabbit IgG (Life Technologies, cat. no. R37116). For
amplification of mCherry signal we used Living Colors® mCherry
Monoclonal Antibody (1:200) (Clontech, cat. no. 632543) as primary
and Alexa-Fluor-568-conjugated goat anti-mouse IgG (H+L) (Life
Technologies, cat. no. A-11004) as secondary antibody. For quantification
of melanocytes, the far-red nuclear counterstain RedDot1 (Cambridge
Biosciences, BT40060) was used. Images of stained embryos/larvae were
taken on an inverted Zeiss 780 confocal microscope or captured using the
Zeiss Z1 Light Sheet microscope.
Tail transection
At 3 dpf, larvae were anaesthetised with 0.02% 3-amino benzoic
acidethylester (Tricaine) in E3 medium and tail transection was performed
with a sterile scalpel.
‘Biotagged’ nuclei isolation
For nuclei isolation, zebrafish embryos were anaesthetised with 0.01%
Tricaine and cranial regions dissected away from anterior yolk sac and ICM.
Embryos were washed in hypotonic buffer H [20 mM HEPES (pH 7.9),
15 mMMgCl2, 10 mMKCl, 1 mMDTT and 1× complete protease inhibitor
(Roche)] and subsequently re-suspended in 500 μl of buffer H. From here,
nuclei isolation was carried out as previously described (Deal and Henikoff,
2010; Trinh et al., 2017). Following isolation, nuclei-beads were
re-suspended in RNA lysis buffer from RNAqueous®-Micro Kit (Life
Technologies, cat. no. AM1931).
RNA extraction, library preparation and RNA-seq analysis
Total nuclear RNAwas extracted using RNAqueous®-Micro Kit according
to the manufacturer’s instructions. RNA integrity was checked with an RNA
Pico chip (Agilent Technologies, cat. no. 5067-1513) using the Agilent
2100 Bioanalyzer.
cDNAwas synthesised and amplified from 100 pg to 1 ng of input RNA
using SMART-seq™ v4 ultra-low input kit for RNA (Clontech
Laboratories, cat. nos 634888, 634889, 634890, 634891, 634892, 634893
and 634894). Sequencing libraries were prepared using the Nextera XT
DNA library preparation kit and NGS was performed on a NextSeq500
platform using a NextSeq™500 150 cycle High Output Kit (Illumina, cat.
no. FC-404-1002) to generate 80-basepair paired end reads.
RNA-seq analysis
Read quality was evaluated using FastQC (Andrews, 2011). Reads were
mapped to the ‘Jul. 2014 Zv10/danRer10 assembly’ version of the zebrafish
genome using STAR (v.2.4.2a) splice-aware aligner (Dobin et al., 2013).
Count tables were generated using subread FeatureCounts (v1.4.5-p1q),
with standard parameters (Liao et al., 2014). Differential expression was
carried out using DESeq2 R package (Love et al., 2014). Data generated in
this study were submitted to GEO (GSE96534).
Quantitative PCR
RNA extraction and cDNA synthesis were carried out using the
RNAqueous®-Micro Kit (Life Technologies, cat. no. AM1931) and
Superscript III Reverse Transcriptase (Invitrogen, cat. no. 18080093),
respectively. Quantitative PCR was performed using Fast SYBR Green
Master Mix (Applied Biosystems, cat. no. 4385612) on a 7500 Fast Real-
Time PCR system (Applied Biosystems). Gene-specific primers were used
for tgm (5′-TGCGATTATGACTGCAAGCA-3′ and 3′-TCCAGCACTT-
CATCAGGTCA), fgf6a (5′-GCCAGACGGAAGGATAAACG-3′ and 3′-
GACAAACAGCCCGCTTTTCA-5′), fgf1 (5′-AAAGCAGTGAAAGCA-
GGAGT-3′ and 3′-AGAAACACTCTTCATTCAGCACA-5′), cathepsin l
(5′-CTGCTGCTTTTCTGGCTGTT-3′ and 3′-ACGGTGTGACTCTTCC-
TCTG-5′), gstp2 (5′-TCTCTTTGGACAGCTGCCTA-3′ and 3′-CGTTC-
TTTCCATACGCACCA-5′), calpain b (5′-AGCTCAGGACTCCTCTCT-
CT-3′ and 3′-CCTTGGCAGATGTCAGTCCT-5′), galectin 3 (5′-GACA-
GCCTGGACAACTGACT-3′ and 3′-AGAGGGAAATCAAGTGGCAC-
5′), galectin 1 (5′-TGTGCTTATACAGAATATGGCCT-3′ and 3′-GCGA-
TGTCTTCAGAGCTGTT-5′), serpinb1l4 (5′-CTCGGTGCCAAAGGA-
AACAC-3′ and 3′-CCATTTGGGCTTCTGGGTTG-5′), cathepsin H
10
RESOURCE ARTICLE Disease Models & Mechanisms (2018) 11, dmm030056. doi:10.1242/dmm.030056
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
(5′-CGTTGTACACCGAGGAAGATG-3′ and 3′-GGTCAATCCTCTTC-
TTGTTCTCC-5′) and dusp23 (5′-CGAGTCGCAGTCAAATCCTG-3′ and
3′-CGTCCTGCCGTGACCATG-5′). Expression levels were normalised to
β-actin.
Statistical analysis
Graphs and statistical analyses were generated by GraphPad prism, version
6. For quantification of the melanocytes and neutrophils, statistical
significance was determined by two-tailed unpaired Student’s t-test with
Welch’s correction. The following P-values are indicated in the figures: not
significant, P>0.05; **P<0.01; ****P<0.0001.
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